Establishment Labs Holdings INC Schedule 13G passive stakes

JW Asset Management, along with affiliated entities, has reported beneficial ownership of 9.15% of Establishment Labs Holdings, Inc. common stock as of June 30, 2026.

Brown Advisory Inc. and its subsidiaries have filed a Schedule 13G reporting a 5.38% beneficial ownership stake in Establishment Labs Holdings Inc.

Nantahala Capital Management and its principals have reduced their beneficial ownership in Establishment Labs Holdings Inc. to below 5%.

Brown Advisory Inc. and its affiliates reported a combined beneficial ownership of 7.02% in Establishment Labs Holdings Inc. as of December 31, 2025.

Nantahala Capital Management, along with Wilmot B. Harkey and Daniel Mack, reported a beneficial ownership of up to 6.91% in Establishment Labs Holdings Inc. as of September 30, 2025.

Capital Research Global Investors has disclosed a 3.5% beneficial ownership stake in Establishment Labs Holdings Inc., holding 1,024,417 common shares.

Qatar Investment Authority has filed an amendment to its Schedule 13G, revealing an 8.27% beneficial ownership stake in Establishment Labs Holdings Inc. as of March 31, 2025.

Brown Advisory Inc. and its affiliated entities have filed a Schedule 13G, reporting a combined passive beneficial ownership of 8.4% in Establishment Labs Holdings Inc.'s common shares.

Nantahala Capital Management, LLC, along with its managing members Wilmot B. Harkey and Daniel Mack, have disclosed beneficial ownership of 5.90% and 6.10% respectively, of Establishment Labs Holdings Inc.'s common shares as of December 31, 2024.

RTW Investments, LP and its Managing Partner, Roderick Wong, M.D., have disclosed a continued beneficial ownership of 9.99% in Establishment Labs Holdings Inc., as detailed in their latest Schedule 13G/A filing.

Capital Research Global Investors has reported a passive beneficial ownership of 6.8% in Establishment Labs Holdings Inc., holding 1,911,525 shares of common stock as of December 31, 2024.

Juan Jose Chacon Quiros has reported beneficial ownership of 5.2% of Establishment Labs Holdings Inc.'s common shares as of December 31, 2024, through direct holdings, stock options, and an LLC.